{"disease":{"id":"igavn","name":"igavn"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07354503","title":"Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Children's Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT07052981","title":"Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"Guixia Ding","has_results":false},{"nct_id":"NCT07024563","title":"Study of Ravulizumab in Pediatric Participants With Primary IgAN","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}